drugset
drugset / Trial / NCT04911413

Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery

NCT04911413 ↗

Phase 4 Completed 210 enrolled Chinese Academy of Medical Sciences, Fuwai Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study compares the effect of three different dose levels of tranexamic acid（TXA）in reducing blood loss and transfusion requirements in cardiac valve surgery.

Timeline

Start
2017-09-01
Primary completion
2021-03-05
Completion
2021-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg —
Subject Tranexamic Acid Small molecule 15 mg/kg —
Subject Tranexamic Acid Small molecule 20 mg/kg —

Indications

cardiac valvular defect